THXBY News Alert Therapix Biosciences (THXBY) 2.1500 02/15/2015
Post# of 64074
Posted On: 02/15/2015 4:46:18 PM
Therapix Biosciences (THXBY) 2.1500 $THXBY
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part III
Anthony Cataldo - at Seeking Alpha - Fri Jan 09, 12:29PM CST
GWPH: 78.09 (+1.70)
China Biotech Week In Review: Otsuka Buys Rights To ARIAD's Leukemia Drug
ChinaBio Today - at Seeking Alpha - Sun Dec 28, 11:30AM CST
Deals and Financings Otsuka Pharma (TYO: 4768) of Japan snagged marketing rights to Iclusig, a leukemia drug developed by ARIAD Pharmaceuticals (NASDAQ: ARIA ), for Japan, China and eight other Asian countries (see story ). Otsuka will pay $77.5...
CRME: 9.76 (-0.14), ARIA: 7.35 (+0.45)
Therapix Biosciences ADRs Begin Trading on the OTCQB(R)
GlobeNewswire - Tue Oct 07, 8:06AM CDT
Therapix Bio (TASE:TRPX) (OTC:THXBY) today announced that its American Depository Receipts (ADRs) have been registered and approved for trading on OTCQB(R). The ADRs, each representing 20 ordinary shares, began trading on October 6, 2014 under the symbol THXBY.
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part III
Anthony Cataldo - at Seeking Alpha - Fri Jan 09, 12:29PM CST
GWPH: 78.09 (+1.70)
China Biotech Week In Review: Otsuka Buys Rights To ARIAD's Leukemia Drug
ChinaBio Today - at Seeking Alpha - Sun Dec 28, 11:30AM CST
Deals and Financings Otsuka Pharma (TYO: 4768) of Japan snagged marketing rights to Iclusig, a leukemia drug developed by ARIAD Pharmaceuticals (NASDAQ: ARIA ), for Japan, China and eight other Asian countries (see story ). Otsuka will pay $77.5...
CRME: 9.76 (-0.14), ARIA: 7.35 (+0.45)
Therapix Biosciences ADRs Begin Trading on the OTCQB(R)
GlobeNewswire - Tue Oct 07, 8:06AM CDT
Therapix Bio (TASE:TRPX) (OTC:THXBY) today announced that its American Depository Receipts (ADRs) have been registered and approved for trading on OTCQB(R). The ADRs, each representing 20 ordinary shares, began trading on October 6, 2014 under the symbol THXBY.
(0)
(0)Scroll down for more posts ▼